Clinical trial
Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
NCT03866603 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
- Lead sponsor
- CENTOGENE GmbH Rostock
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 30, 2019
- Completion date
- October 10, 2024
- Enrollment
- 20,112 (actual)
- Sites
- 110
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson´s disease